Citadel Advisors
PEPLW

Citadel Advisors’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Citadel Advisors’s Portfolio PEPLW Stock Details PEPLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60,808
Closed -$3.17K – 15532
2023
Q3 		$3.17K Buy
60,808
+49,297
+428% +$3.12K ﹤0.01% 13623
2023
Q2 		$233 Buy
11,511
+1,053
+10% +$57 ﹤0.01% 14180
2023
Q1 		$995 Buy
+10,458
New +$878 ﹤0.01% 14383

Other funds holding PEPLW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

Citadel Advisors's PEPLW Position: Q4 2023 in Review

Citadel Advisors sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q4 2023, closing a stake of 60,808 shares — an estimated $3.17K sold.

Citadel Advisors first reported a position in PEPLW in Q1 2023 and held it in 3 quarters. The position peaked at $3.17K in Q3 2023. 17 funds tracked by Wall St. Rank hold PEPLW as of Q4 2023.

  • Citadel Advisors reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 60,808 PepperLime Health Acquisition Corporation Warrrant shares in Q4 2023, an estimated $3.17K.
  • Citadel Advisors first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q1 2023 and held it in 3 quarters.
  • Citadel Advisors's PepperLime Health Acquisition Corporation Warrrant position peaked at $3.17K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.